undamentalytics Newsletter
Sign in

Quaker Chemical Corp (KWR) stock

Add to watchlist

Add holding +

NYSE: KWR NYSE Specialty Chemicals Next results ~January 28, 2027

C+ Fundamentals grade

Quaker Chemical Corp is a US-listed company in the specialty chemicals industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$110

Cash-flow model

Base case. Range ~$70–$160 across our lower- and higher-growth cases (-0.2%–9.8% a year).

Price vs value

Modestly overvalued

The price is inside our value range, 38% above our base value.

Price used: $148.05, November 2, 2026

Quaker Chemical Corp valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 2 selling0 purchases and 2 sales by directors and officers, last 12 monthsInsider trades
  • Funds161 adding, 120 cuttingOf 40 active managers that changed their stake, 18 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Quaker Chemical files

10-Q filed October 29: Quaker Chemical

Model value +1.7%

Quaker Chemical's revenue for the twelve months to September 2026 reached $2.03bn, up 8.7% on the year, an acceleration from 7.8% growth a quarter earlier. Free-cash-flow margin, however, slipped to 1.9% from 5.2%, even as operating margin widened to 7.6% from 2.7%. Our model value has edged up from $127 to $129 a share, still well below the $158 share price. We keep the rating at Hold. At the current price, the market appears to be pricing in cash-flow growth of around 6.9% a year over five years, well ahead of the 2.8% a year revenue growth the company has actually delivered.

Source: 10-Q filed October 29, 2026 on SEC EDGAR · Financials · Valuation

Earlier notes (1)

Where Quaker Chemical stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $1.98bn, up 7.8% on a year earlier, faster than the 6.3% growth a quarter earlier. Free-cash-flow margin fell to 3.8% from 6.5% a year earlier. Operating margin widened to 7.7% from 3.0%. The diluted share count is down 2.3% on a year earlier, which lifts each remaining share. Against its peers on growth, profitability, cash generation and balance sheet, it grades C. It passes 1 of our 7 financial-health checks. Our cash-flow model value is $127 a share, against a share price of $156. At that price, our model says the market is pricing in about 6.6% a year of cash-flow growth for five years, faster than the 2.3% a year revenue growth it has delivered.

10-Q on SEC EDGAR

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~January 28, 2027 (estimated)

Quaker Chemical Corp's trailing-twelve-month revenue grew 8.7% year on year, with a free-cash-flow margin of 1.9%. Where it lags: days sales outstanding of 88 days ranks 27 of 30 specialty chemicals companies we cover.

Our discounted-cash-flow model values the business at ~$110 per share in the base case (~$70–$160 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Revenue growth accelerating: TTM revenue growth rose to 8.7% (+0.9pp vs the prior quarter).

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Margins widening. Operating margin is up 4.9 points on a year ago.
  • Shrinking share count. Diluted shares fell 1.8% in a year, so each share owns more of the business.
  • Estimates rising. Analysts' consensus for next year's earnings per share has risen 8.5% over 90 days.

Things to watch

  • Priced above our value. The share price of $148.05 is 27% above our value per share of $110.
  • Weak cash conversion. Free cash flow was 41% of net income over the last 12 months.
  • Below peers: days sales outstanding. Days sales outstanding of 88 days ranks 27 of 30 specialty chemicals companies we cover (median 59 days).
  • Heavily shorted. 15.2% of the shares available to trade are sold short (12.3 days of average volume to cover).

Latest results: FY2026 Q3

Filed October 29, 2026
Earnings per share
$2.39 against an average estimate of $2.10: beat by 13.8%
Revenue
$545m, up 10.3% on a year earlier
Share reaction
-3.8% in the first session after the results on October 29, 2026, against -2.1% for the S&P 500
Next report
October 29, 2026; average EPS estimate $1.80

Quaker Chemical's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-1.9%
  • 1 week-4.4%
  • 1 month-7.6%
  • This year+9.3%
  • 1 year+8.1%
  • 5 years-39.7%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$2B
Operating margin
7.6%
Net margin
4.8%
EPS (TTM, diluted)
$5.62

Growth

Revenue growth
+8.7%
Change in growth rate
+0.9 pts
Share count change
−1.8%

Cash

Free cash flow (TTM)
$39.4M
FCF margin
1.9%
Stock pay % of revenue
0.7%

Earnings

Last results
October 29, 2026
Next results (est.)
January 28, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Leadership
  3. Agreement
  4. Leadership
  5. Results
  6. Leadership

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Quaker Chemical Corp valuation models and calculator

What the price is pricing in

The share price implies about 8.9% a year of cash-flow growth for five years.That is faster than the 2.8% a year revenue growth Quaker Chemical has delivered.

  • Priced in8.9%
  • Last 12 months8.7%
  • 3 years a year0.9%
  • 5 years a year2.8%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($148.38, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Sell12-month view
12-month price target
~$110
Price used
$148.38close November 3, 2026
Implied change
▼ 27%
Uncertainty
High

How we got here: a discounted-cash-flow model of Quaker Chemical Corp's free cash flow after stock-based pay with after-tax interest added back ($134M, FY2026 Q3 TTM), growing 4.2% and 4.7% in the next two years (forecasts, guidance and its record), then back to 4.8% by year five, and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$70–~$160 ; that spread sets a 35% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of Quaker Chemical Corp's free cash flow after stock-based pay ( $134M, FY2026 Q3 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Quaker Chemical Corp as an operating company, with every model that fits that kind of business. Cost of equity 9.4%: the 10-year Treasury yield (4.9%) plus a beta of 0.99 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$110 ~$70–$160 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$140 ~$110–$160 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$45 ~$31–$65 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$27 ~$24–$31 Left out: out of range vs price (0.18x)
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$99 ~$45–$140 3 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Quaker Chemical Corp with Specialty Chemicals in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −43%
  • Revenue growth 5 points higher ▲ +56%
  • Free-cash-flow margin 1 point lower ▼ −50%
  • Last year's free-cash-flow margin change, if it persists ▼ −62%
  • Discount rate 1 point higher ▼ −26%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $69$110$163$233$325$444
8.5% $43$72$111$161$226$310
10% $27$49$79$118$167$231

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$68.63$115.40$137.36$163.33$152.46$236.92$217.20$158.77$205.03$136.58$135.44$148.05
Market value$907m$1.5bn$1.8bn$2.2bn$2.3bn$4.2bn$3.9bn$2.8bn$3.7bn$2.4bn$2.4bn$2.6bn
+ Net debt (− = net cash)$1m−$22m−$23m−$68m$811m$717m$736m$782m$584m$556m$726m$728m
Enterprise value$908m$1.5bn$1.8bn$2.1bn$3.1bn$4.9bn$4.6bn$3.6bn$4.3bn$3.0bn$3.1bn$3.3bn
Multiples
Price / sales 1.2x2.0x2.2x2.5x2.0x3.0x2.2x1.5x1.9x1.3x1.3x1.3x
Price / earnings 17.7x24.7x89.7x36.5x73.1x106.0x32.0x—32.6x20.9x—26.3x
Price / free cash flow 14.5x23.8x33.8x33.0x34.6x26.2x141.1xn/m15.3x15.0x29.4x64.9x
EV / EBITDA 11.1x16.2x25.6x22.1x42.6x42.1x21.7x32.0x15.5x11.7x26.0x14.7x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

54 /100

Moderate moat

How hard Quaker Chemical's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 6 / 20

    Cash operating profit has been a median 5.6% of total assets over 10 years.

  • Pricing power 13 / 20

    Gross margin has been a median 35.7%, moving by 1.5 percentage points (standard deviation) across 10 years.

  • Durability 6 / 20

    Operating margin has been a median 7.4%; its worst year was 2.7%.

  • Cash conversion 12 / 20

    Free cash flow was positive in 9 of 10 years, at a median 5.7% of revenue.

  • Discipline 18 / 20

    The diluted share count fell 3.1% over five years; stock-based pay has been a median 0.6% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $7.87 +12% $2.0bn +8%
Next $9.56 +22% $2.1bn +5%

Next year's EPS estimate has moved +8.5% in 90 days, across 7 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +11.6% on 90 days ago. In the last 30 days, 1 analyst raised Quaker Chemical Corp's forecast and 0 cut it.

Consensus EPS forecast Quaker Chemical Corp, last 90 days
$7.00 $8.00 $9.00 $10.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $7.05 Current fiscal year, 60 days ago: $7.83 Current fiscal year, 30 days ago: $7.86 Current fiscal year, 7 days ago: $7.87 Current fiscal year, Now: $7.87 $7.87 Next fiscal year, 90 days ago: $8.81 Next fiscal year, 60 days ago: $9.41 Next fiscal year, 30 days ago: $9.51 Next fiscal year, 7 days ago: $9.53 Next fiscal year, Now: $9.56 $9.56

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $7.05$8.81
60 days ago $7.83$9.41
30 days ago $7.86$9.51
7 days ago $7.87$9.53
Now $7.87$9.56

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $2.10 $2.39 +13.8%
Jun 2026 $1.66 $2.19 +31.9%
Mar 2026 $1.62 $1.63 +0.5%
Dec 2025 $1.75 $1.65 −5.9%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, July 30, 2026

No numeric guidance in Quaker Chemical Corp's latest earnings release (filed July 30, 2026). Some companies give their outlook only on the earnings call.

How our valuation uses these forecasts

Our cash-flow model grows Quaker Chemical Corp's revenue by +4.2% next year and +4.7% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+3.8%, weight 66%) and the company's own record (+4.8%, weight 34%) . How the weights are set.

Analyst recommendations

7 analysts, Oct 2026
Buy7100%
Hold00%
Sell00%

Monthly trend

  1. Oct 2026257
  2. Sep 2026257
  3. Aug 2026257
  4. Jul 2026257

Counts of recommendations published by analysts covering Quaker Chemical Corp, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
15.2%
of tradable shares
Days to cover
12.29
at average volume
Short interest, 1 month
−4%
to October 15, 2026
Held by institutions
93%
of shares
Held by insiders
22.2%
of shares
Employees
4,700
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +8.1%

$137.00 on October 31, 2025 to $148.05

ThenNowEffect
Revenue (last 12 months) $1.8bn $2.0bn +7.8%
P/S multiple 1.3x 1.3x −2.0%
Share count 18m 17m +2.3%

Biggest factor: revenue. Loss-making at one end, so the split uses price/sales.

Last 3 years −4.5%

$154.99 on November 3, 2023 to $148.05

ThenNowEffect
Revenue (last 12 months) $2.0bn $2.0bn +0.1%
Net margin 0.4% 4.9% +1009.7%
P/E multiple n/m 26.2x −91.7%
Share count 18m 17m +3.3%

Biggest factor: p/e multiple.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
KWR−8%−27%+29%−33%−1%+9%
Industry peers (median)+19%−25%−9%+7%−15%+5%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
KWR58%33%58%33%50%55%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
KWR−26%−45%−35%−35%−33%−37%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 66% from February 22, 2021 to April 8, 2025. Getting back needed a 195% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$113.54 – $178.67
From 52-week high
−17.1%
vs 50-day average
−6.3%
vs 200-day average
−0.8%
Volatility (1 year)
36%
Beta vs S&P 500
1.28

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
7 up, 5 down
typical move ±4.5%
After a week
7 up, 4 down
typical move ±6.7%
After a month
6 up, 5 down
typical move ±9.3%
Results releasedNext dayS&P 500 next day5 days21 days
October 29, 2026 −3.8% −2.1% — —
July 30, 2026 +7.9% +2.4% +12.4% +11.5%
April 30, 2026 +6.9% +1.3% +7.3% +6.9%
February 23, 2026 −9.2% −0.3% −16.4% −30.4%
October 30, 2025 +6.5% −0.8% +1.1% +4.2%
July 31, 2025 +2.8% −2.0% +10.1% +26.5%
May 1, 2025 −2.3% +2.2% −1.3% −1.7%
February 24, 2025 +1.9% −1.0% −5.8% −6.9%
October 31, 2024 +4.2% −1.5% +9.9% +3.5%
August 5, 2024 −6.5% −2.0% −7.7% −3.3%
May 2, 2024 −1.0% +2.2% +1.1% −4.7%
February 29, 2024 +0.5% +1.3% +0.2% +2.8%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Options strategies

All options ideas

How Quaker Chemical Corp’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.

Cash-secured put

Not offered: rated Sell.

We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.

Covered call

Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.

For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.

Collar

Not offered: no liquid put and call pair for the same expiry.

For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

Quaker Chemical Corp in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Quaker Chemical Corp
$1.8B $1.9B $2B $2.1B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $2B Revenue (TTM), FY24 Q1: $1.9B Revenue (TTM), FY24 Q2: $1.9B Revenue (TTM), FY24 Q3: $1.9B Revenue (TTM), FY24 Q4: $1.8B Revenue (TTM), FY25 Q1: $1.8B Revenue (TTM), FY25 Q2: $1.8B Revenue (TTM), FY25 Q3: $1.9B Revenue (TTM), FY25 Q4: $1.9B Revenue (TTM), FY26 Q1: $1.9B Revenue (TTM), FY26 Q2: $2B Revenue (TTM), FY26 Q3: $2B $2B

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $2B
FY24 Q1 $1.9B
FY24 Q2 $1.9B
FY24 Q3 $1.9B
FY24 Q4 $1.8B
FY25 Q1 $1.8B
FY25 Q2 $1.8B
FY25 Q3 $1.9B
FY25 Q4 $1.9B
FY26 Q1 $1.9B
FY26 Q2 $2B
FY26 Q3 $2B
Revenue growth, TTM YoY Quaker Chemical Corp
-10% -5% 0% 5% 10% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: 0.5% Revenue growth, TTM YoY, FY24 Q1: -2.4% Revenue growth, TTM YoY, FY24 Q2: -4.1% Revenue growth, TTM YoY, FY24 Q3: -5.5% Revenue growth, TTM YoY, FY24 Q4: -5.8% Revenue growth, TTM YoY, FY25 Q1: -5.7% Revenue growth, TTM YoY, FY25 Q2: -3.1% Revenue growth, TTM YoY, FY25 Q3: 0.1% Revenue growth, TTM YoY, FY25 Q4: 2.7% Revenue growth, TTM YoY, FY26 Q1: 6.3% Revenue growth, TTM YoY, FY26 Q2: 7.8% Revenue growth, TTM YoY, FY26 Q3: 8.7% 8.7%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 0.5%
FY24 Q1 -2.4%
FY24 Q2 -4.1%
FY24 Q3 -5.5%
FY24 Q4 -5.8%
FY25 Q1 -5.7%
FY25 Q2 -3.1%
FY25 Q3 0.1%
FY25 Q4 2.7%
FY26 Q1 6.3%
FY26 Q2 7.8%
FY26 Q3 8.7%
Operating margin (TTM) Quaker Chemical Corp
0% 5% 10% 15% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Operating margin (TTM), FY23 Q4: 11.0% Operating margin (TTM), FY24 Q1: 11.4% Operating margin (TTM), FY24 Q2: 11.7% Operating margin (TTM), FY24 Q3: 11.5% Operating margin (TTM), FY24 Q4: 10.6% Operating margin (TTM), FY25 Q1: 9.2% Operating margin (TTM), FY25 Q2: 3.0% Operating margin (TTM), FY25 Q3: 2.7% Operating margin (TTM), FY25 Q4: 2.8% Operating margin (TTM), FY26 Q1: 3.1% Operating margin (TTM), FY26 Q2: 7.7% Operating margin (TTM), FY26 Q3: 7.6% 7.6%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q4 11.0%
FY24 Q1 11.4%
FY24 Q2 11.7%
FY24 Q3 11.5%
FY24 Q4 10.6%
FY25 Q1 9.2%
FY25 Q2 3.0%
FY25 Q3 2.7%
FY25 Q4 2.8%
FY26 Q1 3.1%
FY26 Q2 7.7%
FY26 Q3 7.6%
FCF margin (TTM) Quaker Chemical Corp
0% 5% 10% 15% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: 12.3% FCF margin (TTM), FY24 Q1: 12.0% FCF margin (TTM), FY24 Q2: 10.8% FCF margin (TTM), FY24 Q3: 10.1% FCF margin (TTM), FY24 Q4: 8.8% FCF margin (TTM), FY25 Q1: 6.9% FCF margin (TTM), FY25 Q2: 6.5% FCF margin (TTM), FY25 Q3: 5.2% FCF margin (TTM), FY25 Q4: 4.3% FCF margin (TTM), FY26 Q1: 4.6% FCF margin (TTM), FY26 Q2: 3.8% FCF margin (TTM), FY26 Q3: 1.9% 1.9%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 12.3%
FY24 Q1 12.0%
FY24 Q2 10.8%
FY24 Q3 10.1%
FY24 Q4 8.8%
FY25 Q1 6.9%
FY25 Q2 6.5%
FY25 Q3 5.2%
FY25 Q4 4.3%
FY26 Q1 4.6%
FY26 Q2 3.8%
FY26 Q3 1.9%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Sept 2026
Income
Revenue 451 544 683 708 729 766 738 747 820 868 1,134 1,418 1,761 1,944 1,953 1,840 1,889 2,026
Gross profit — — — — — — — 280 291 312 392 513 595 613 706 686 679 725
EBITDA 36 47 55 59 75 82 82 92 70 95 73 117 213 113 275 256 119 224
Operating income 26 48 58 63 71 77 75 85 63 88 46 59 150 52 214 195 53 154
Net income 17 31 45 47 56 56 51 61 20 59 32 40 121 −16 113 117 −2 97
Diluted EPS $1.47 $2.80 $3.66 $3.63 $4.27 $4.26 $3.84 $4.63 $1.52 $4.45 $2.08 $2.22 $6.77 −$0.89 $6.26 $6.51 −$0.14 $5.62
Growth (year on year)
Revenue — +20.5% +25.6% +3.7% +3.0% +5.0% −3.7% +1.2% +9.8% +5.8% +30.7% +25.1% +24.2% +10.4% +0.5% −5.8% +2.7% +8.7%
EBITDA — +32.0% +17.0% +8.1% +26.7% +8.7% −0.4% +13.4% −24.1% +35.7% −23.1% +59.5% +82.4% −46.9% +143.5% −7.1% −53.5% +96.2%
Operating income — +84.5% +20.3% +9.2% +12.7% +8.6% −3.6% +14.5% −26.5% +39.9% −47.4% +28.7% +153.5% −65.2% +310.1% −9.2% −72.8% +203.9%
Net income — +79.9% +43.3% +4.0% +20.2% +0.3% −9.4% +20.0% −67.0% +193.3% −46.8% +25.4% +206.0% −113.1% — +3.5% −102.1% —
Diluted EPS — +90.5% +30.7% −0.8% +17.6% −0.2% −9.9% +20.6% −67.2% +192.8% −53.3% +6.7% +205.0% −113.1% — +4.0% −102.2% —
Margins
Gross margin — — — — — — — 37.5% 35.5% 36.0% 34.6% 36.2% 33.8% 31.5% 36.1% 37.3% 36.0% 35.8%
EBITDA margin 7.9% 8.6% 8.1% 8.4% 10.3% 10.7% 11.1% 12.4% 8.6% 11.0% 6.5% 8.2% 12.1% 5.8% 14.1% 13.9% 6.3% 11.1%
Operating margin 5.8% 8.8% 8.5% 8.9% 9.8% 10.1% 10.1% 11.4% 7.7% 10.1% 4.1% 4.2% 8.5% 2.7% 11.0% 10.6% 2.8% 7.6%
Net margin 3.9% 5.8% 6.6% 6.6% 7.7% 7.4% 6.9% 8.2% 2.5% 6.9% 2.8% 2.8% 6.9% −0.8% 5.8% 6.3% −0.1% 4.8%
Free-cash-flow margin 6.2% 5.2% 1.1% 7.1% 8.5% 5.4% 8.5% 8.5% 6.6% 7.6% 5.9% 11.3% 1.6% 0.7% 12.3% 8.8% 4.3% 1.9%
Cash flow
Cash from operations 42 38 20 63 74 55 73 74 65 79 82 178 49 42 279 205 136 94
Capital spending 14 9 12 13 11 13 11 10 11 13 16 18 21 29 39 42 56 55
Free cash flow 28 28 8 50 62 42 62 64 54 66 67 160 27 13 240 163 81 39
Stock-based pay 2 3 4 4 4 5 6 6 4 4 5 11 11 12 15 15 14 14
Free cash flow after stock pay 26 25 4 46 58 36 56 57 50 62 62 149 16 2 226 148 67 26
Balance sheet
Cash 25 17 33 33 68 65 81 89 90 104 124 182 165 181 195 189 180 167
Total debt 0 75 47 31 19 76 82 66 67 37 935 899 901 963 778 745 905 895
Net debt (negative = net cash) −25 58 15 −1 −50 11 1 −22 −23 −68 811 717 736 782 584 556 726 728
Diluted shares — 11m 12m 13m 13m 13m 13m 13m 13m 13m 15m 18m 18m 18m 18m 18m 17m 17m
Returned to shareholders
Dividends 10 10 12 13 13 15 17 18 19 19 22 28 29 30 32 33 34 35
Buybacks — — — — 0 0 7 6 0 0 — — — 0 0 49 42 —
Total returned 10 10 12 13 13 15 24 23 19 19 22 28 29 30 32 82 76 35

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 7 checks passed · September 30, 2026
What it owns · $2.9bn
Short-term assets $1.0bnLonger-term assets $1.9bn
What it owes, and who funded it · $2.9bn
Short-term liabilities $426mLonger-term liabilities $1.1bnShareholders' equity $1.4bn
  • Short-term assets cover short-term liabilities $1.0bn of assets due within a year against $426m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $1.0bn short-term assets against $1.1bn of longer-dated liabilities.
  • More cash than debt $167m of cash against $892m of debt.
  • Debt below 40% of shareholders' equity Debt is 63% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 62% to 63% over five years.
  • A year's operating cash flow covers at least 20% of debt $94m of operating cash flow against $892m of debt.
  • Operating profit covers interest at least five times over Operating income of $154m against $41m of interest.

From Quaker Chemical Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Dividends (TTM)
$35.2M
Buybacks, last 3 fiscal years
$90.8M
Diluted share count
−1.8%
year over year
Total shareholder yield
1.4%
dividends 1.4% + buybacks 0.0% of market value
Dividend payout ratio
36%
of net income paid out
Sales & admin spending
26.8%
of revenue
Days sales outstanding
88 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in specialty chemicals
Last 12 months unless stated KWR MTX IOSP ASH SXT SCL Median
Revenue, last 12 months $2.0bn $2.2bn $1.8bn $1.8bn $1.7bn $2.4bn $906m
Revenue growth, last 12 months 8.7% 4.8% 2.9% −1.4% 9.5% 7.6% 5.4%
Revenue growth, 3-year average 0.9% 0.3% −2.9% −7.2% 6.3% −1.9% 0.9%
Revenue growth, latest quarter 10.3% 4.2% 11.8% 7.3% 10.6% 15.0% 8.3%
Gross margin 35.8% 23.9% 27.5% 31.5% 35.1% 11.8% 28.8%
Operating margin 7.6% −1.6% 7.0% 7.4% 14.5% 0.8% 4.3%
Operating margin, 3-year average 7.3% 4.8% 8.5% −13.0% 12.7% 2.3% 5.5%
Net margin 4.8% −3.1% 6.6% 2.8% 9.7% −0.1% 0.8%
Cash from operations / revenue 4.6% 10.8% 6.7% 18.2% 6.9% 6.4% 6.9%
Free-cash-flow margin 1.9% 5.9% 3.7% 13.6% −1.0% 1.5% 4.3%
Free-cash-flow margin, 3-year average 5.8% 6.3% 5.9% 11.3% 3.3% 1.1% 5.1%
Stock pay / revenue 0.7% — 0.6% 1.0% 1.0% 0.3% 1.0%
Change in share count −1.8% −2.2% −1.1% −9.2% 0.5% −0.0% 0.1%

Median of all 42 companies we cover in specialty chemicals. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

42 specialty chemicals companies
Measure Company Peer median Rank
Revenue growth Growth 8.7% 6.0% 14 of 42
Change in growth rate Growth +0.9pp +1.3pp 25 of 42
Gross margin Profitability 35.8% 31.5% 12 of 40
Operating margin Profitability 7.6% 3.8% 15 of 39
Net margin Profitability 4.8% 1.7% 17 of 42
Free-cash-flow margin Cash generation 1.9% 4.8% 24 of 42
Stock pay as % of revenue Cash generation 0.7% 1.0% 14 of 36
Long-term debt as % of assets Balance sheet 29.9% 26.8% 22 of 36
Change in share count Balance sheet -1.8% 0.0% 9 of 37
Days sales outstanding Balance sheet 88 days 59 days 27 of 30

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue Share YoY
Other Non US Excluding China $1B 53.8% ▲ 4.5%
United States $622M 33.0% ▼ 2.4%
China $251M 13.3% ▲ 8.9%

From Quaker Chemical Corp's 10-K filed February 23, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$2.5B
Institutions reporting
309
Shares held vs prior quarter
▲ 0.7%
Positions opened / closed
51 / 23

Top buyers and sellers, Q2 2026: 161 institutions bought and 120 sold ; the biggest buyer was First Eagle Investment Management, LLC (+231K shares) and the biggest seller T. Rowe Price Investment Management, Inc (−148K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $335M 2.1M 13.4% ▲ 4.3%
Vanguard Portfolio Management LLC $150M 945K 6.0% ▲ 1.7%
Royce & Associates LP $137M 860K 5.4% ▲ 4.4%
Dimensional Fund Advisors LP $123M 776K 4.9% ▲ 3.4%
Wellington Management Group LLP $108M 680K 4.3% ▼ 9.2%
Vanguard Capital Management LLC $99.1M 624K 3.9% 0.0%
Morgan Stanley $91.1M 574K 3.6% ▼ 6.6%
State Street Corp $90.7M 571K 3.6% ▲ 5.3%
Nomura Asset Management International Inc. $69.3M 436K 2.8% ▲ 27.8%
William Blair Investment Management, LLC $66.8M 421K 2.7% ▲ 8.3%
Gw&K Investment Management, LLC $62.3M 392K 2.5% ▼ 0.9%
Geode Capital Management, LLC $56.4M 355K 2.2% ▲ 5.5%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Quaker Chemical Corp's complete shareholder register. Values are as reported by the filers ; 1 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $207,544 2 trades by 2 insiders · 0% under pre-set plans
Net ▼ $207,544 net selling
Insider Date Trade Shares Price Value
Osborne William H Director August 4, 2026 Sell 600 $168.31 $100,986
Bijlani Jeewat EVP, Glob. Spec. & CGO May 26, 2026 Sell 731 $145.77 $106,558

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around January 28, 2027 estimated from the company's past filing pattern, not announced

  • October 29, 2026
  • July 30, 2026
  • April 30, 2026
  • February 23, 2026
  • October 30, 2025
  • July 31, 2025

Recent SEC filings

Data status

When each part of this page on Quaker Chemical Corp was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Quaker Chemical Corp in brief

What does Quaker Chemical Corp do?
Quaker Chemical Corp is a US-listed company in the specialty chemicals industry. Its financial year ends in December.
What is Quaker Chemical Corp's stock ticker?
Quaker Chemical Corp trades under the ticker KWR on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Quaker Chemical Corp's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Quaker Chemical Corp reported revenue of $2B, 8.7% higher than a year earlier, according to its SEC filings.
What is Quaker Chemical Corp's free cash flow?
Quaker Chemical Corp's free-cash-flow margin is 1.9% of revenue over the trailing twelve months, ranking 24 of the 42 specialty chemicals companies we cover.
What is Quaker Chemical Corp's fair value (intrinsic value) per share?
Our discounted-cash-flow model of Quaker Chemical Corp's free cash flow after stock-based pay gives ~$110 per share in the base case, and ~$70–$160 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are Quaker Chemical Corp's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vanguard Portfolio Management LLC and Royce & Associates LP. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Quaker Chemical Corp's market cap?
On November 2, 2026, Quaker Chemical Corp's market capitalisation was about $2.6B, with a price-to-earnings ratio of 26.3 and net debt of $728M. Market figures come from third-party market data and may be delayed.
Does Quaker Chemical Corp pay a dividend?
Yes: Quaker Chemical Corp paid $35.2M in dividends over the trailing twelve months, a dividend yield of 1.38% and a payout ratio of 36.2%.
How much debt does Quaker Chemical Corp have?
Quaker Chemical Corp's debt-to-equity ratio is 63.1%, from its latest balance sheet (61.5% five years earlier). The financial health section below sets out its other solvency checks.
Who are Quaker Chemical Corp's competitors?
In our Specialty Chemicals peer group, the companies closest to Quaker Chemical Corp are Minerals Technologies Inc, Innospec Inc., Ashland Inc., Sensient Technologies Corp and Stepan Co. The side-by-side comparison below sets their revenue, margins and growth against Quaker Chemical Corp's.
Are insiders buying or selling Quaker Chemical Corp stock?
Over the last 12 months, Quaker Chemical Corp's directors and officers reported 0 open-market purchases and 2 sales on Form 4. The insider trading page charts every trade.
When is Quaker Chemical Corp's next earnings date?
Around January 28, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Quaker Chemical Corp announces its own schedule.